Keep up with the latest happenings in Erba

Transasia brings forth the latest trends in Biochemistry and Hematology

Date : 24 Jun, 2018

Organizes a knowledge sharing platform - Transasia Scientific Seminar (TSS) Ace in East Delhi

  • TSS- Ace is an unique initiative by Transasia Bio-Medicals Ltd. to offer a knowledge and expertise sharing platform
  • Pathologists and clinicians discuss the latest advances in laboratory automation
  • Receives a welcoming response from over 70 pathologists from Delhi and nearby areas

New Delhi, 23rd Jun, 2018: Transasia Bio-Medicals Ltd., India’s leading In-vitro Diagnostic Company recently organized a scientific seminar in East Delhi on the latest advancements in biochemistry and hematology for laboratories. Titled Transasia Scientific Seminar (TSS) Ace, this pioneering academic initiative aims at encouraging the exchange of technical know-how among doctors. The seminar focused on biochemistry and hematology - two of the most critical areas for in-vitro diagnostics. 

The session on ‘Effective Use of Database Systems by doctors’ by Dr. (Col.) Arun Harith (Sr. Consultant & Head of Department-Biochemistry, Medanta Medicity, New Delhi) highlighted the growing need of database for improving test outcomes. On the other hand, Dr. (Col.) Jyoti Kotwal (Chairperson & Prof.- Dept. of Hematology, Sir Gangaram Hospital, New Delhi) spoke on ‘Clinical Utility of Advanced Hematology Parameters.’ She emphasized on how the latest automation in hematology helps in enumeration of the different parameters such as IPF, Ret He, Immature Granulocytes, NRBC, etc. and how these parameters help in early diagnosis of diseases.

The sessions were chaired by Dr. Meera Sikka (Head of Dept.- Pathology University College of Medical Sciences).

Transasia offers the entire range of semi and fully automated analyzers and reagents in Biochemistry and Hematology. The latest in clinical chemistry is a fully automated, random access clinical chemistry analyzer,  XL 1000 with a throughput of 1040 tests/ hr. It offers a host of key features such as sample clot detection, permanent hard glass cuvettes and four channel direct ISE measurement, among others, making it an ideal choice for high volume labs.

The seminar received an overwhelming response with full-house participation. The over 70 attendees comprised pathologists, physicians and clinicians from reputed Government institutions such as Delhi Cancer institute, IHBAS, Swami Dayanand Hospital, Rajiv Gandhi Super Specialty Hospital, Hegdewar Hospital, LBS Hospital and private institutes such as MAX Healthcare, Kailash Healthcare Ltd., Yashoda Super Specialty Hospital, Dr. Lal PathLabs, Metropolis, SRL Diagnostics, etc.

Speaking on the occasion a spokesperson for Transasia Bio-Medicals Ltd. said,

“There is an alarming burden on the society from both communicable and non communicable diseases in India. 70% of the treatment decisions are based on lab results. Yet, less than 30% of the Indian population has ever got their blood test done. The major chunk of the 70% population is in the smaller towns. At Transasia, we are committed to reaching out to the pathologists and clinicians in every nook and corner of the country, so that they are well equipped to cater to this population.TSS Ace is a unique platform that empowers the pathologists with the technological advances and encourages exchange of scientific updates, backed by expertise and experience. ”

Over the years, TSS Ace has grown in popularity and has become Transasia’s identity. It has been well accepted as a successful forum and benefits more than 800 pathologists and clinicians annually.

About Transasia Bio-Medicals Ltd. 

Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. 

Transasia provides doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems, with an impressive install base of above 65,000 equipments across India. It has a vast network of the more than 250 service engineers, 400+ sales and marketing team, 23 zonal offices and 350+ distributors.

It is the first Indian company to manufacture and export blood analyzers and reagents, in the 1990s. Today, Transasia’s indigenous research has resulted in development of state of the art, ‘Make in India’ products and technologies, enabling its products to be among the best in the world. 
All along its journey spanning more than three decades, Transasia has been recognized for its commitment to healthcare. It has been conferred ‘Global Growth Company-2014’ by the World Economic Forum amongst many others.

Headquartered in Mumbai, Transasia is a part of the global Erba Diagnostics Mannheim GmbH Group. The Erba –Transasia Group has spread its footprint across USA, UK, Germany, Czech Republic, France, Italy, Russia and Turkey through various acquisitions.

Erba’s production sites in India, Czech Republic and USA and R&D centres in France, UK, India and Czech Republic form a hub for indigenous manufacturing of world class deliverables.Today, the Erba -Transasia Group serves millions across 110 countries. 

For further information, kindly visit